Citations

Clear

5 citation(s) found for "Montaser, Alaa".

Collision Skull Base Tumors: Chondrosarcoma and Juvenile Nasopharyngeal Angiofibroma. Case Report and Review of Literature
Breen, Joseph T. , Donaldson, Angela M. , Ravindran, Krishnan , Montaser, Alaa S. , Tawk, Rabih G. , Byrne, Richard W.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 27, 2026 | Volume: 87 | Issue: No issue available | Pages: No page available

10.1055/s-0046-1819082 Get It

Indications for cerebral revascularization for moyamoya syndrome in pediatric sickle cell disease determined by Delphi methodology
Robert, Adam , Adelson, P. David, Lang, Shih‐Shan , Grabb, Paul A. , Greene, Stephanie , Leonard, Jeffrey, Magge, Suresh N. , Marupudi, Neena I. , Sillero, Rafael de Oliveira , Smith, Edward R. , Smith, Jodi L. , Strahle, Jennifer M. , Vadivelu, Sudhakar , Wellons, John C. , Wrubel, David, Hatem, Asmaa, Moody, C, Han, Sabrina H. , Millican, Nicklaus , Dain, Aleksandra S. , Beslow, Lauren A. , Aldana, Philipp R. , Montaser, Alaa, Smith, Edward , Hanel, Ricardó A. , Johnston, James M. , Piatt, Joseph H. , Hatem, Asmaa, Montaser, Alaa S. , Pederson, John M.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | July 24, 2024 | Volume: 34 | Issue: 4 | Pages: 402-413

10.3171/2024.5.peds2426 | PMID 39029127 Get It

OBJECTIVE Cerebral revascularization surgery (CRS) has been used to prevent stroke in children with sickle cell disease (SCD) and cerebral vasculopathy (e.g., moyamoya syndrome). While results suggest that it may be an effective treatment, surgical indications have not been well defined. This study sought to determine indications for offering revascularization surgery in centers with established sickle cell programs in the US. METHODS Three sequential surveys utilizing the Delphi methodology were administered to neurosurgeons participating in the Stroke in Sickle Cell Revascularization Surgery study. Respondents were presented with clinical scenarios of patients with SCD and varying degrees of ischemic presentation and vasculopathy, and the group’s agreement to offer surgical revascularization was measured. Consensus was defined as ≥ 75% similar responses. RESULTS The response rate to all 3 surveys was 100%. Seventeen neurosurgeons from 16 different centers participated. The presence of moyamoya collaterals (MMCs) and arterial stenosis matching an ischemic distribution yielded the strongest recommendations to offer surgery. There was consensus to offer revascularization in the presence of MMCs and at least 50% arterial stenosis matching an ischemic distribution. In contrast, there was no consensus to offer revascularization with 50%–70% stenosis not matching an ischemic presentation in the absence of MMCs. The presence of the ivy sign in the distribution of the stenotic artery also contributed to the consensus to offer surgery in certain scenarios. CONCLUSIONS There were several clinical scenarios that attained consensus to offer surgery; the strongest was moderate to severe arterial stenosis that matched the distribution of ischemic presentation in the presence of MMCs. Radiological findings of decreased cerebral flow or perfusion also facilitated attaining consensus to offer surgery. The findings of this study reflect expert opinion about questions that deserve prospective clinical research. Determination of indications for CRS can guide clinical practice and aid the design of prospective studies.
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection
Nguyen, Ryan, Ravindran, Krishnan , Perez‐Vega, Carlos , Dominari, Asmina, Battistin, Umberto , Suárez-Meade, Paola , Kalani, Maziyar A. , Rose, Peter S. , Bydon, Mohamad , Dominari, Asimina , Montaser, Alaa, Perez-Vega, Carlos, Lee, Seung-Jin, Moussalem, Charbel, Ghaith, Abdul Karim , Nguyen, Ryan, El-Hajj, Victor Gabriel , Montaser, Alaa S. , Biase, Gaetano De , Lee, Seung Jin, Moussalem, Charbel K. , Patel, Naresh P. , Clarke, Michelle J. , Abode-Iyamah, Kingsley , Akinduro, Oluwaseun O.

Mayo Clinic

Neurosurgical Focus | May 4, 2024 | Volume: 56 | Issue: 5 | Pages: E9

10.3171/2024.2.focus23927 | PMID 38691864 Get It

OBJECTIVE Chordomas are rare tumors of the skull base and spine believed to arise from the vestiges of the embryonic notochord. These tumors are locally aggressive and frequently recur following resection and adjuvant radiotherapy. Proton therapy has been introduced as a tissue-sparing option because of the higher level of precision that proton-beam techniques offer compared with traditional photon radiotherapy. This study aimed to compare recurrence in patients with chordomas receiving proton versus photon radiotherapy following resection by applying tree-based machine learning models. METHODS The clinical records of all patients treated with resection followed by adjuvant proton or photon radiotherapy for chordoma at Mayo Clinic were reviewed. Patient demographics, type of surgery and radiotherapy, tumor recurrence, and other variables were extracted. Decision tree classifiers were trained and tested to predict long-term recurrence based on unseen data using an 80/20 split. RESULTS Fifty-three patients with a mean ± SD age of 55.2 ± 13.4 years receiving surgery and adjuvant proton or photon therapy to treat chordoma were identified; most patients were male. Gross-total resection was achieved in 54.7% of cases. Proton therapy was the most common adjuvant radiotherapy (84.9%), followed by conventional or external-beam radiation therapy (9.4%) and stereotactic radiosurgery (5.7%). Patients receiving proton therapy exhibited a 40% likelihood of having recurrence, significantly lower than the 88% likelihood observed in those treated with nonproton therapy. This was confirmed on logistic regression analysis adjusted for extent of tumor resection and tumor location, which revealed that proton adjuvant radiotherapy was associated with a decreased risk of recurrence (OR 0.1, 95% CI 0.01–0.71; p = 0.047) compared with photon therapy. The decision tree algorithm predicted recurrence with an accuracy of 90% (95% CI 55.5%–99.8%), with the lowest risk of recurrence observed in patients receiving gross-total resection with adjuvant proton therapy (23%). CONCLUSIONS Following resection, adjuvant proton therapy was associated with a lower risk of chordoma recurrence compared with photon therapy. The described machine learning models were able to predict tumor progression based on the extent of tumor resection and adjuvant radiotherapy modality used.
Frailty as a Predictor of Postoperative Morbidity and Mortality in Patients Aged 80 Years and Older Undergoing Instrumented Fusion
Moniz‐Garcia, Diogo , Odeh, Nour , Genel, Oktay , Sousa‐Pinto, Bernardo , Otamendi-Lopez, Andrea, Nottmeier, Eric W. , Bydon, Mohamad , McClendon, Jamal, Buchanan, Ian A. , Pirris, Stephen M. , Chen, Selby , Montaser, Alaa, Nottmeier, Eric, Pirris, Stephen , Garcia, Diogo Moniz , Montaser, Alaa S. , Biase, Gaetano De , Abode-Iyamah, Kingsley

Mayo Clinic

Operative Neurosurgery | January 8, 2024 | Volume: 26 | Issue: 6 | Pages: 669-676

10.1227/ons.0000000000001040 | PMID 38189376 Get It

BACKGROUND AND OBJECTIVES: Degenerative spine disease is a leading cause of disability, with increasing prevalence in the older patients. While age has been identified as an independent predictor of outcomes, its predictive value is limited for similar older patients. Here, we aimed to determine the most predictive frailty score of adverse events in patients aged 80 and older undergoing instrumented lumbar fusion. METHODS: We proceeded with a multisite (3 tertiary academic centers) retrospective review including patients undergoing instrumented fusion aged 80 and older from January 2010 to present. A composite end point encompassing 30-day return to operating room, readmission, and mortality was created. We estimated the area under the receiver operating characteristic curve for frailty scores (Modified Frailty Index-5 [MFI-5], Modified Frailty Index-11 [MFI-11], and Charlson Comorbidity Index [CCI]) in relation to that composite score. In addition, we estimated the association between each score and the composite end point by means of logistic regression. RESULTS: A total of 153 patients with an average age of 85 years at the time of surgery were included. We observed a 30-day readmission rate of 11.1%, reoperation of 3.9%, and mortality of 0.6%. The overall rate of the composite end point at 30 days was 25 (15.1%). The AUC for MFI-5 was 0.597 (0.501-0.693), for MFI-11 was 0.620 (0.518-0.723), and for CCI was 0.564 (0.453-0.675). The association between the scores and composite end point did not reach statistical significance for MFI-5 (odds ratio [OR] = 1.45 [0.98-2.15], P = .061) and CCI (OR = 1.13 [0.97-1.31], P = .113) but was statistically significant for MFI-11 (OR = 1.46 [1.07-2.00], P = .018). CONCLUSION: This is the largest study comparing frailty index scores in octogenarians undergoing instrumented lumbar fusion. Our findings suggest that while MFI-11 score correlated with adverse events, the predictive ability of existing scores remains limited, highlighting the need for better approaches to identify select patients at age extremes.
Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya
Montaser, Alaa S., Srinivasan, Harishchandra Lalgudi, Staffa, Steven J., Zurakowski, David, Slingerland, Anna L., Orbach, Darren B., Hausman-Kedem, Moran, Roth, Jonathan, Smith, Edward R., Smith, Edward R. , Orbach, Darren B. , Orbach, Darren B , Smith, Edward , Montaser, Alaa S., Srinivasan, Harishchandra Lalgudi, Staffa, Steven J., Zurakowski, David, Slingerland, Anna L. , Hausman-Kedem, Moran, Roth, Jonathan, Smith, Edward R.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | December 31, 2021 | Volume: 29 | Issue: 4 | Pages: 458-466

10.3171/2021.11.peds21384 | PMID 34972077 Get It

OBJECTIVE Ivy sign is a radiographic finding on FLAIR MRI sequences and is associated with slow cortical blood flow in moyamoya. Limited data exist on the utility of the ivy sign as a diagnostic and prognostic tool in pediatric patients, particularly outside of Asian populations. The authors aimed to investigate a modified grading scale with which to characterize the prevalence and extent of the ivy sign in children with moyamoya and evaluate its efficacy as a biomarker in predicting postoperative outcomes, including stroke risk. METHODS Pre- and postoperative clinical and radiographic data of all pediatric patients (21 years of age or younger) who underwent surgery for moyamoya disease or moyamoya syndrome at two major tertiary referral centers in the US and Israel, between July 2009 and August 2019, were retrospectively reviewed. Ivy sign scores were correlated to Suzuki stage, Matsushima grade, and postoperative stroke rate to quantify the diagnostic and prognostic utility of ivy sign. RESULTS A total of 171 hemispheres in 107 patients were included. The median age at the time of surgery was 9 years (range 3 months–21 years). The ivy sign was most frequently encountered in association with Suzuki stage III or IV disease in all vascular territories, including the anterior cerebral artery (53.7%), middle cerebral artery (56.3%), and posterior cerebral artery (47.5%) territories. Following surgical revascularization, 85% of hemispheres with Matsushima grade A demonstrated a concomitant, statistically significant reduction in ivy sign scores (OR 5.3, 95% CI 1.4–20.0; p = 0.013). Postoperatively, revascularized hemispheres that exhibited ivy sign score decreases had significantly lower rates of postoperative stroke (3.4%) compared with hemispheres that demonstrated no reversal of the ivy sign (16.1%) (OR 5.5, 95% CI 1.5–21.0; p = 0.008). CONCLUSIONS This is the largest study to date that focuses on the role of the ivy sign in pediatric moyamoya. These data demonstrate that the ivy sign was present in approximately half the pediatric patients with moyamoya with Suzuki stage III or IV disease, when blood flow was most unstable. The authors found that reversal of the ivy sign provided both radiographic and clinical utility as a prognostic biomarker postoperatively, given the statistically significant association with both better Matsushima grades and a fivefold reduction in postoperative stroke rates. These findings can help inform clinical decision-making, and they have particular value in the pediatric population, as the ability to minimize additional radiographic evaluations and tailor radiographic surveillance is requisite.